Alpha Tau Medical Ltd.
DRTSNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for DRTS. That does not mean none is planned.
Get an email about DRTS's next catalysts
Track Alpha Tau Medical (DRTS) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 1 past
DRTS Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.14 | FQ end Sep/2026 | Call: tbd
How DRTS's past catalysts played out
Market Overview
Stock performance and key metrics
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Alpha Tau Medical Ltd.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in Alpha Tau Medical Ltd.'s (DRTS) pipeline across Phase 3, Phase 2. Its lead program is AZD3759 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Alpha Tau Medical Ltd.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Alpha Tau Medical Ltd. (DRTS) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track DRTS biotech catalysts?→
Add DRTS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Alpha Tau Medical Ltd.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.